NCT06121726

Brief Summary

Inguinal hernia repair is a common surgical procedure done as day surgery. Because patients need to be discharged on the same day, the choice of anesthesia technique is influenced. One option is the ilioinguinal (II)-iliohypogastric (IH) nerve block, a type of transversus abdominis plane (TAP) block, which has benefits such as faster recovery, better pain control, and reduced opioid use. It also allows for quick discharge, early feeding, and no need for post-anesthesia or recovery unit stay. This study aims to evaluate the success of the II-IH nerve block as the preferred anesthesia strategy for patients undergoing unilateral inguinal hernia repair using the Lichtenstein technique. The study will analyze various factors such as BMI, age, optimal ultrasound vision, amount of anesthesia used, dose of anesthesia administered, time between block execution and incision, and sedative dose needed to determine independent variables of block effectiveness. The study will include patients aged 18 or older, with ASA I-II-III classification, and who provide informed consent. Patients with allergies to local anesthetics, certain medical conditions, obesity, difficulty visualizing target structures, non-cooperative behavior, or taking anticoagulant therapy will be excluded. The study will be conducted at the Sant'Antonio Hospital (Padova University Hospital) operating rooms for one year, aiming to recruit around 400 patients. Informed consent for data processing will be obtained during the preoperative anesthesia visit, and standard anesthesia procedures will be followed during the surgery. As usual care the patient will be monitored before surgery using an electrocardiogram, oxygen saturation measurement, and non-invasive blood pressure. After adequate sedation, the II-IH nerve block will be performed under sterile conditions and ultrasound guidance. Participation in the study does not modify the commonly used anesthesia procedures and does not pose any additional risks or provide direct benefits to the patients. The data collected will be treated confidentially and used exclusively for the study's purposes. Data collection will be conducted through a paper-based form, and only a few variables will be recorded. The study's findings will be made public, even if negative, and will be submitted to the ethics committee within twelve months of data collection completion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
343

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 13, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

October 13, 2023

Completed
26 days until next milestone

First Posted

Study publicly available on registry

November 8, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 2, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 2, 2025

Completed
Last Updated

May 7, 2025

Status Verified

May 1, 2025

Enrollment Period

1.6 years

First QC Date

October 13, 2023

Last Update Submit

May 4, 2025

Conditions

Keywords

ilioinguinaliliohypogastricnerve blockpainhernia

Outcome Measures

Primary Outcomes (1)

  • ilioinguinal-iliohypogastric nerve block failure

    Described as the need of additional local anesthetic, additional opioids and/or general anesthesia

    through surgery completation, an average of 1 hour

Secondary Outcomes (6)

  • Total body weight (kg) as predictive parameter for ilioinguinal-iliohypogastric nerve block failure

    through surgery completation, an average of 1 hour

  • Time From Block To Skin Incision(minutes) As Predictive Parameter For ilioinguinal-iliohypogastric nerve block failure

    through surgery completation, an average of 1 hour

  • Dose of anesthetic(mg) As Predictive Parameter For ilioinguinal-iliohypogastric nerve block failure

    through surgery completation, an average of 1 hour

  • Local anesthetic volume(mL) As Predictive Parameter For ilioinguinal-iliohypogastric nerve block failure

    through surgery completation, an average of 1 hour

  • Age(years) As Predictive Parameter For ilioinguinal-iliohypogastric nerve block failure

    through surgery completation, an average of 1 hour

  • +1 more secondary outcomes

Study Arms (1)

Ilioinguinal-Iliohypogastric nerve block

Patients will receive Ilioinguinal-Iliohypogastric nerve block as standard of care

Other: Ilioinguinal-Iliohypogastric nerve blockDrug: Local anesthetic

Interventions

local anesthetic will be administered near ilioinguinal-iliohypogastric nerves under ultrasound guidance. Given the observational nature of the study dose and drugs will be decided by the attending anesthesiologist

Ilioinguinal-Iliohypogastric nerve block

Given the observational nature of the study dose and drugs will be decided by the attending anesthesiologist

Ilioinguinal-Iliohypogastric nerve block

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients undergoing unilateral inguinal hernioplasty

You may qualify if:

  • \>18 years old
  • Informed consent
  • Unilateral inguinal hernioplasty program using the Lichtenstein technique

You may not qualify if:

  • Allergy to local anesthesia
  • Cardiac, renal, hepatic, central or peripheral neuropathies that are not compensated
  • Anticoagulant therapy
  • History of coagulopathy (evaluate risk/benefit ratio)
  • Infection at the surgical site
  • Non-cooperative patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Padova

Padua, Veneto, 35127, Italy

Location

MeSH Terms

Conditions

Hernia, InguinalPain, PostoperativePainHernia

Interventions

Anesthetics, Local

Condition Hierarchy (Ancestors)

Hernia, AbdominalPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic ProcessesNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

AnestheticsCentral Nervous System DepressantsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesSensory System AgentsPeripheral Nervous System AgentsCentral Nervous System AgentsTherapeutic Uses

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

October 13, 2023

First Posted

November 8, 2023

Study Start

October 13, 2023

Primary Completion

May 2, 2025

Study Completion

May 2, 2025

Last Updated

May 7, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations